Evidence map›Paper›PMID 33979192›Full record

ArticleHealth affairs (Project Hope)2021

Racial/Ethnic Disparities In COVID-19 Exposure Risk, Testing, And Cases At The Subcounty Level In California.

Marissa B Reitsma, Anneke L Claypool, Jason Vargo, Priya B Shete, Ryan McCorvie, William H Wheeler, David A Rocha, Jennifer F Myers, Erin L Murray, Brooke Bregman and 8 more

Abstract read
In one paragraph

Article in Health affairs (Project Hope), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed.

  1. Family Check-Up Online: Effects of a Virtual Randomized Trial on Parent Stress, Parenting, and Child Outcomes in Early Adolescence.Prevention science : the official journal of the Society for Prevention Research · 2026
    Trial
  2. Trial
  3. A language-matching model to improve equity and efficiency of COVID-19 contact tracing.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Marissa B ReitsmaMarissa B. Reitsma is a PhD student in the Centers for Health Policy and Primary Care and Outcomes Research, Stanford Health Policy, Freeman Spogli Institute for International Studies and the Stanford School of Medicine, Stanford University, in Stanford, California. She and Anneke Claypool contributed equally to this article.
Anneke L ClaypoolAnneke L. Claypool is a PhD candidate in the Department of Management Science and Engineering, Stanford University. She and Marissa Reitsma contributed equally to this article.
Jason VargoJason Vargo is a lead research scientist in the Climate Change and Health Equity Program, Coronavirus Sciences Branch, and the Office of Health Equity, California Department of Public Health (CDPH), in Richmond, California.
Priya B ShetePriya B. Shete is an assistant professor in the Division of Pulmonary and Critical Care Medicine and UCSF Center for Tuberculosis, University of California San Francisco, and the COVID-19 modeling and analytics lead in the Coronavirus Sciences Branch, CDPH.
Ryan McCorvieRyan McCorvie is a statistician in the Coronavirus Sciences Branch, CDPH.
William H WheelerWilliam H. Wheeler is a clinical informatics specialist in the Coronavirus Sciences Branch and the Division of Communicable Disease Control, CDPH.
David A RochaDavid A. Rocha is a clinical informatics specialist in the Coronavirus Sciences Branch and the Division of Communicable Disease Control, CDPH.
Jennifer F MyersJennifer F. Myers is a senior informatics specialist in the Coronavirus Sciences Branch and the Division of Communicable Disease Control, CDPH.
Erin L MurrayErin L. Murray is an epidemiologist supervisor in the Coronavirus Sciences Branch and the Division of Communicable Disease Control, CDPH.
Brooke BregmanBrooke Bregman is a senior epidemiologist in the Coronavirus Sciences Branch and the Division of Communicable Disease Control, CDPH.
Deniz M DominguezDeniz M. Dominguez is a surveillance program manager in the Coronavirus Sciences Branch and the Division of Communicable Disease Control, CDPH.
Alyssa D NguyenAlyssa D. Nguyen is a research scientist in the Coronavirus Sciences Branch and the Division of Communicable Disease Control, CDPH.
Charsey PorseCharsey Porse is an epidemiologist in the Coronavirus Sciences Branch and the Division of Communicable Disease Control, CDPH.
Curtis L FritzCurtis L. Fritz is the State Public Health Veterinarian in the Coronavirus Sciences Branch and the Division of Communicable Disease Control, CDPH.
Seema JainSeema Jain is the chief of the Disease Investigations Section, Infectious Diseases Branch, the Coronavirus Sciences Branch, and the Division of Communicable Disease Control, CDPH.
James P WattJames P. Watt is the chief of the Division of Communicable Disease Control, Coronavirus Sciences Branch, and the Division of Communicable Disease Control, CDPH.
Joshua A SalomonJoshua A. Salomon is a professor in the Centers for Health Policy and Primary Care and Outcomes Research, Stanford Health Policy, Freeman Spogli Institute for International Studies and the Stanford School of Medicine, Stanford University.
Jeremy D Goldhaber-FiebertJeremy D. Goldhaber-Fiebert (jeremygf@stanford.edu) is an associate professor in the Centers for Health Policy and Primary Care and Outcomes Research, Stanford Health Policy, Freeman Spogli Institute for International Studies and the Stanford School of Medicine, Stanford University.

Funding

Stanford Center for Clinical & Translational Education and Research (Spectrum)UL1TR003142 · NCATS · STANFORD UNIVERSITY · PI O'HARA, RUTH M · 2019 to 2023
$45.0M
Making Better Decisions: Policy Modeling for AIDS and Drug AbuseR37DA015612 · NIDA · STANFORD UNIVERSITY · PI DOUGLAS K OWENS · 2019 to 2026
$6.3M
NCATS NIH HHS UL1 TR003142NIDA NIH HHS R37 DA015612
6 · The paper itself

Abstract

With a population of forty million and substantial geographic variation in sociodemographics and health services, California is an important setting in which to study disparities. Its population (37.5 percent White, 39.1 percent Latino, 5.3 percent Black, and 14.4 percent Asian) experienced 59,258 COVID-19 deaths through April 14, 2021-the most of any state. We analyzed California's racial/ethnic disparities in COVID-19 exposure risks, testing rates, test positivity, and case rates through October 2020, combining data from 15.4 million SARS-CoV-2 tests with subcounty exposure risk estimates from the American Community Survey. We defined "high-exposure-risk" households as those with one or more essential workers and fewer rooms than inhabitants. Latino people in California are 8.1 times more likely to live in high-exposure-risk households than White people (23.6 percent versus 2.9 percent), are overrepresented in cumulative cases (3,784 versus 1,112 per 100,000 people), and are underrepresented in cumulative testing (35,635 versus 48,930 per 100,000 people). These risks and outcomes were worse for Latino people than for members of other racial/ethnic minority groups. Subcounty disparity analyses can inform targeting of interventions and resources, including community-based testing and vaccine access measures. Tracking COVID-19 disparities and developing equity-focused public health programming that mitigates the effects of systemic racism can help improve health outcomes among California's populations of color.

Indexed as

COVID-19EthnicityCaliforniaHealth Status DisparitiesHumansMinority GroupsSARS-CoV-2United States

Identifiers

PMID33979192
PMCPMC8458028

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.